TSH and FT4 Reference Interval Recommendations and Prevalence of Gestational Thyroid Dysfunction: Quantification of Current Diagnostic Approaches

Author:

Osinga Joris A J12ORCID,Derakhshan Arash12ORCID,Feldt-Rasmussen Ulla34ORCID,Huang Kun5,Vrijkotte Tanja G M6,Männistö Tuija7,Bassols Judit8,López-Bermejo Abel910ORCID,Aminorroaya Ashraf11,Vafeiadi Marina12,Broeren Maarten A C13,Palomaki Glenn E14ORCID,Ashoor Ghalia15,Chen Liangmiao16,Lu Xuemian16,Taylor Peter N17ORCID,Tao Fang-Biao1819,Brown Suzanne J20ORCID,Sitoris Georgiana21,Chatzi Lida22,Vaidya Bijay23,Popova Polina V2425,Vasukova Elena A24,Kianpour Maryam10,Suvanto Eila26,Grineva Elena N24,Hattersley Andrew27ORCID,Pop Victor J M28,Nelson Scott M29ORCID,Walsh John P2030,Nicolaides Kypros H31,D’Alton Mary E32,Poppe Kris G21ORCID,Chaker Layal1233,Bliddal Sofie3ORCID,Korevaar Tim I M12

Affiliation:

1. Department of Internal Medicine, Erasmus University Medical Center , 3000 CA Rotterdam , The Netherlands

2. Academic Center for Thyroid Diseases, Erasmus University Medical Center , 3000 CA Rotterdam , The Netherlands

3. Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet , 2100 Copenhagen , Denmark

4. Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University , 1172 Copenhagen , Denmark

5. Department of Maternal, Child and Adolescent Health, Scientific Research Center in Preventive Medicine, School of Public Health, Anhui Medical University , 230032 Anhui , China

6. Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute , 1081 HV Amsterdam , The Netherlands

7. Northern Finland Laboratory Center Nordlab and Medical Research Center Oulu, Oulu University Hospital and University of Oulu , 90570 Oulu , Finland

8. Maternal-Fetal Metabolic Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital , 17007 Girona , Spain

9. Pediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital , 17007 Girona , Spain

10. Departament de Ciències Mèdiques, Universitat de Girona , 17003 Girona , Spain

11. Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences , 81745-33871 Isfahan , Iran

12. Department of Social Medicine, School of Medicine, University of Crete , Heraklion, 710 03 Crete , Greece

13. Laboratory of Clinical Chemistry and Hematology, Máxima Medical Centre , 5504 DB Veldhoven , The Netherlands

14. Department of Pathology and Laboratory Medicine, Women & Infants Hospital and Alpert Medical School at Brown University , Providence, RI 02903, USA

15. Harris Birthright Research Center for Fetal Medicine, King’s College Hospital , SE5 9RS London , UK

16. Department of Endocrinology and Rui’an Center of the Chinese-American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University , 325035 Wenzhou , China

17. Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine , CF10 3EU Cardiff , UK

18. Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University , 230032 Anhui , China

19. Anhui Provincial Key Laboratory of Population Health & Aristogenics , Hefei, 230032 Anhui , China

20. Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital , 6009 Nedlands, Perth , Australia

21. Endocrine Unit, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB) , 1000 Brussels , Belgium

22. Department of Preventive Medicine, Keck School of Medicine, University of Southern California , Los Angeles, CA 90089 , USA

23. Department of Endocrinology, Royal Devon and Exeter Hospital NHS Foundation Trust, University of Exeter Medical School , EX1 2LU Exeter , UK

24. Institute of Endocrinology, Almazov National Medical Research Centre , 197341 Saint Petersburg , Russia

25. World-Class Research Center for Personalized Medicine, Almazov National Medical Research Centre , 197341 Saint Petersburg , Russia

26. Department of Obstetrics and Gynecology and Medical Research Center Oulu, University of Oulu , 90570 Oulu , Finland

27. Molecular Medicine, University of Exeter Medical School , Royal Devon & Exeter Hospital, EX3 0AW Exeter , UK

28. Department of Medical and Clinical Psychology, Tilburg University , 5000 LE Tilburg , The Netherlands

29. School of Medicine, University of Glasgow , G12 8QQ Glasgow , UK

30. Medical School, University of Western Australia , Crawley, WA 6009 , Australia

31. Department of Women and Children’s Health, Faculty of Life Sciences and Medicine King’s College London , SE5 9RS London , UK

32. Department of Obstetrics and Gynecology, Columbia University Irving Medical Center , NewYork, NY 10032 , USA

33. Department of Epidemiology, Erasmus University Medical Center , 3000 CA Rotterdam , The Netherlands

Abstract

Abstract Context Guidelines recommend use of population- and trimester-specific thyroid-stimulating hormone (TSH) and free thyroxine (FT4) reference intervals (RIs) in pregnancy. Since these are often unavailable, clinicians frequently rely on alternative diagnostic strategies. We sought to quantify the diagnostic consequences of current recommendations. Methods We included cohorts participating in the Consortium on Thyroid and Pregnancy. Different approaches were used to define RIs: a TSH fixed upper limit of 4.0 mU/L (fixed limit approach), a fixed subtraction from the upper limit for TSH of 0.5 mU/L (subtraction approach) and using nonpregnancy RIs. Outcome measures were sensitivity and false discovery rate (FDR) of women for whom levothyroxine treatment was indicated and those for whom treatment would be considered according to international guidelines. Results The study population comprised 52 496 participants from 18 cohorts. Compared with the use of trimester-specific RIs, alternative approaches had a low sensitivity (0.63-0.82) and high FDR (0.11-0.35) to detect women with a treatment indication or consideration. Sensitivity and FDR to detect a treatment indication in the first trimester were similar between the fixed limit, subtraction, and nonpregnancy approach (0.77-0.11 vs 0.74-0.16 vs 0.60-0.11). The diagnostic performance to detect overt hypothyroidism, isolated hypothyroxinemia, and (sub)clinical hyperthyroidism mainly varied between FT4 RI approaches, while the diagnostic performance to detect subclinical hypothyroidism varied between the applied TSH RI approaches. Conclusion Alternative approaches to define RIs for TSH and FT4 in pregnancy result in considerable overdiagnosis and underdiagnosis compared with population- and trimester-specific RIs. Additional strategies need to be explored to optimize identification of thyroid dysfunction during pregnancy.

Funder

Netherlands Organization for Scientific Research

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3